Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study

Brain, Behavior, and Immunity

Volumn 75, Issue , 2019, Pages 200-207

  Huang, Minxuan ^a   Su, Shaoyong ^b   Goldberg, Jack ^c,d   Miller, Andrew H ^e   Levantsevych, Oleksiy M ^a   Shallenberger, Lucy ^a   Pimple, Pratik ^a   Pearce, Bradley ^a   Bremner, J Douglas ^e,f   Vaccarino, Viola ^a,e  

^a EMORY UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Depression; Inflammation; Twins; Veterans

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERLEUKIN 6; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DIZYGOTIC TWINS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TWIN STUDY; TWINS; BLOOD; COMPLICATION; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; VETERAN;

BIOMARKERS; C-REACTIVE PROTEIN; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; VETERANS;

EID: 85055744775     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2018.10.007     Document Type: Article

References (67)

1. Kessler, R.C., Berglund, P., Demler, O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:23 (2003), 3095–3105.
2. Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., Walters, E.E., Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62:6 (2005), 617–627.
3. Ariyo, A.A., Haan, M., Tangen, C.M., et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102:15 (2000), 1773–1779.
4. Gan, Y., Gong, Y., Tong, X., et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry, 14, 2014, 371.
5. Lichtman, J.H., Froelicher, E.S., Blumenthal, J.A., et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129:12 (2014), 1350–1369.
6. Lesperance, F., Frasure-Smith, N., Theroux, P., Irwin, M., The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 161:2 (2004), 271–277.
7. Tully, P.J., Baumeister, H., Bengel, J., et al. The longitudinal association between inflammation and incident depressive symptoms in men: the effects of hs-CRP are independent of abdominal obesity and metabolic disturbances. Physiol. Behav. 139 (2015), 328–335.
8. Haapakoski, R., Mathieu, J., Ebmeier, K.P., Alenius, H., Kivimaki, M., Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 49 (2015), 206–215.
9. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G., Jones, P.B., Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:10 (2014), 1121–1128.
10. Shishehbor, M.H., Aviles, R.J., Brennan, M.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289:13 (2003), 1675–1680.
11. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71:2 (2009), 171–186.
12. Whooley, M.A., Caska, C.M., Hendrickson, B.E., Rourke, M.A., Ho, J., Ali, S., Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry 62:4 (2007), 314–320.
13. Chocano-Bedoya, P.O., Mirzaei, F., O'Reilly, E.J., et al. C-reactive protein, interleukin-6, soluble tumor necrosis factor alpha receptor 2 and incident clinical depression. J. Affect. Disord. 163 (2014), 25–32.
14. Kern, P.A., Ranganathan, S., Li, C., Wood, L., Ranganathan, G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:5 (2001), E745–751.
15. Yudkin, J.S., Kumari, M., Humphries, S.E., Mohamed-Ali, V., Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148:2 (2000), 209–214.
16. Libby, P., Theroux, P., Pathophysiology of coronary artery disease. Circulation 111:25 (2005), 3481–3488.
17. Danesh, J., Muir, J., Wong, Y.K., Ward, M., Gallimore, J.R., Pepys, M.B., Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur. Heart J. 20:13 (1999), 954–959.
18. Valkanova, V., Ebmeier, K.P., Allan, C.L., CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150:3 (2013), 736–744.
19. Zalli, A., Jovanova, O., Hoogendijk, W.J., Tiemeier, H., Carvalho, L.A., Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berl.) 233:9 (2016), 1669–1678.
20. Au, B., Smith, K.J., Gariepy, G., Schmitz, N., The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA). Int. J. Geriatr. Psychiatry 30:9 (2015), 976–984.
21. Danner, M., Kasl, S.V., Abramson, J.L., Vaccarino, V., Association between depression and elevated C-reactive protein. Psychosom. Med. 65:3 (2003), 347–356.
22. Miller, G.E., Freedland, K.E., Carney, R.M., Stetler, C.A., Banks, W.A., Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav. Immun. 17:4 (2003), 276–285.
23. Copeland, W.E., Shanahan, L., Worthman, C., Angold, A., Costello, E.J., Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol. Psychiatry 71:1 (2012), 15–21.
24. Liu, Y., Al-Sayegh, H., Jabrah, R., Wang, W., Yan, F., Zhang, J., Association between C-reactive protein and depression: modulated by gender and mediated by body weight. Psychiatry Res. 219:1 (2014), 103–108.
25. Vogelzangs, N., Duivis, H.E., Beekman, A.T., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry., 2, 2012, e79.
26. Laake, J.P., Stahl, D., Amiel, S.A., et al. The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care. 37:8 (2014), 2186–2192.
27. Su, S., Zhao, J., Bremner, J.D., et al. Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ. Cardiovasc. Genet. 2:6 (2009), 614–620.
28. Bufalino, C., Hepgul, N., Aguglia, E., Pariante, C.M., The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav. Immun. 31 (2013), 31–47.
29. Leonard, B.E., Inflammation and depression: a causal or coincidental link to the pathophysiology?. Acta Neuropsychiatr., 2017, 1–16.
30. Burt, S.A., McGue, M., Iacono, W.G., Nonshared environmental mediation of the association between deviant peer affiliation and adolescent externalizing behaviors over time: results from a cross-lagged monozygotic twin differences design. Dev. Psychol. 45:6 (2009), 1752–1760.
31. Vaccarino, V., Khan, D., Votaw, J., et al. Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins. J. Am. Coll. Cardiol. 57:11 (2011), 1271–1279.
32. Vaccarino, V., Brennan, M.L., Miller, A.H., et al. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol. Psychiatry 64:6 (2008), 476–483.
33. Tsai, M., Mori, A.M., Forsberg, C.W., et al. The Vietnam Era Twin Registry: a quarter century of progress. Twin Res. Hum. Genet. 16:1 (2013), 429–436.
34. Scherrer, J.F., Xian, H., Bucholz, K.K., et al. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom. Med. 65:4 (2003), 548–557.
35. Huang, M., Shah, A., Su, S., et al. Association of depressive symptoms and heart rate variability in vietnam war-era twins: a longitudinal twin difference study. JAMA Psychiatry, 2018.
36. Forsberg, C.W., Goldberg, J., Sporleder, J., Smith, N.L., Determining zygosity in the Vietnam era twin registry: an update. Twin Res. Hum. Genet. 13:5 (2010), 461–464.
37. Beck, A.T., Steer, R.A., Ball, R., Ranieri, W., Comparison of beck depression inventories-IA and -II in psychiatric outpatients. J. Pers. Assess. 67:3 (1996), 588–597.
38. Osman, A., Kopper, B.A., Barrios, F., Gutierrez, P.M., Bagge, C.L., Reliability and validity of the Beck depression inventory–II with adolescent psychiatric inpatients. Psychol. Assess. 16:2 (2004), 120–132.
39. Storch, E.A., Roberti, J.W., Roth, D.A., Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory-Second Edition in a sample of college students. Depress. Anxiety 19:3 (2004), 187–189.
40. Baecke, J.A., Burema, J., Frijters, J.E., A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 36:5 (1982), 936–942.
41. Richardson, M.T., Ainsworth, B.E., Wu, H.C., Jacobs, D.R. Jr., Leon, A.S., Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity. Int. J. Epidemiol. 24:4 (1995), 685–693.
42. Cecil, C.A., Barker, E.D., Jaffee, S.R., Viding, E., Association between maladaptive parenting and child self-control over time: cross-lagged study using a monozygotic twin difference design. Br. J. Psychiatry 201:4 (2012), 291–297.
43. Carlin, J.B., Gurrin, L.C., Sterne, J.A., Morley, R., Dwyer, T., Regression models for twin studies: a critical review. Int. J. Epidemiol. 34:5 (2005), 1089–1099.
44. Halaris, A., Myint, A.M., Savant, V., et al. Does escitalopram reduce neurotoxicity in major depression?. J. Psychiatr. Res. 66–67 (2015), 118–126.
45. Raedler, T.J., Inflammatory mechanisms in major depressive disorder. Curr. Opin. Psychiatry 24:6 (2011), 519–525.
46. Hashmi, A.M., Butt, Z., Umair, M., Is depression an inflammatory condition? a review of available evidence. J. Pak. Med. Assoc. 63:7 (2013), 899–906.
47. Hannestad, J., DellaGioia, N., Bloch, M., The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:12 (2011), 2452–2459.
48. McGue, M., Osler, M., Christensen, K., Causal inference and observational research: the utility of twins. Perspect. Psychol. Sci. 5:5 (2010), 546–556.
49. Kop, W.J., Gottdiener, J.S., Tangen, C.M., et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89:4 (2002), 419–424.
50. Ford, D.E., Erlinger, T.P., Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 164:9 (2004), 1010–1014.
51. Panagiotakos, D.B., Pitsavos, C., Chrysohoou, C., et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur. Heart J. 25:6 (2004), 492–499.
52. Dantzer, R., Aubert, A., Bluthe, R.M., et al. Mechanisms of the behavioural effects of cytokines. Adv. Exp. Med. Biol. 461 (1999), 83–105.
53. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56.
54. Menard, C., Pfau, M.L., Hodes, G.E., et al. Social stress induces neurovascular pathology promoting depression. Nat. Neurosci. 20:12 (2017), 1752–1760.
55. Felger, J.C., Haroon, E., Woolwine, B.J., Raison, C.L., Miller, A.H., Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus. Physiol. Behav. 166 (2016), 14–21.
56. Felger, J.C., Lotrich, F.E., Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246 (2013), 199–229.
57. Raison, C.L., Miller, A.H., Is depression an inflammatory disorder?. Curr. Psychiatry Rep. 13:6 (2011), 467–475.
58. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 65:9 (2009), 732–741.
59. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun. 23:7 (2009), 936–944.
60. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., Cleare, A.J., Inflammation and clinical response to treatment in depression: a meta-analysis. Eur. Neuropsychopharmacol. 25:10 (2015), 1532–1543.
61. Ma, Y., Chiriboga, D.E., Pagoto, S.L., et al. Association between depression and C-reactive protein. Cardiol. Res. Pract., 2011, 2010, 286509.
62. Irwin, M.R., Olmstead, R., Carrillo, C., et al. Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep 37:9 (2014), 1543–1552.
63. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16:1 (2016), 22–34.
64. Kohler, O., Benros, M.E., Nordentoft, M., et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71:12 (2014), 1381–1391.
65. Niles, A.N., Smirnova, M., Lin, J., O'Donovan, A., Gender differences in longitudinal relationships between depression and anxiety symptoms and inflammation in the health and retirement study. Psychoneuroendocrinology 95 (2018), 149–157.
66. Derry, H.M., Padin, A.C., Kuo, J.L., Hughes, S., Kiecolt-Glaser, J.K., Sex differences in depression: does inflammation play a role?. Curr. Psychiatry Rep., 17(10), 2015, 78.
67. Rothman, K.J., Gallacher, J.E., Hatch, E.E., Why representativeness should be avoided. Int. J. Epidemiol. 42:4 (2013), 1012–1014.